APO Research
Talk to an analyst

APO RESEARCH · REPORT

AI Clinical Endpoint Assessment Software

Compare research editions
View pricing & licenses

Selected research

Industry Research

AI Clinical Endpoint Assessment Software Industry Research Report 2026

12 August 2026138 pages

Choose your research edition.

Industry ResearchAI Clinical Endpoint Assessment Software Industry Research Report 2026138 pages · $2,950 USDIndustry Growth & TrendsGlobal AI Clinical Endpoint Assessment Software Industry Growth and Trends Forecast to 2032123 pages · $3,450 USDMarket StructureGlobal AI Clinical Endpoint Assessment Software Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal AI Clinical Endpoint Assessment Software Market Outlook and Growth Opportunities 2026210 pages · $4,250 USDMarket Analysis & ForecastGlobal AI Clinical Endpoint Assessment Software Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

The global AI Clinical Endpoint Assessment Software market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.

North America: the AI Clinical Endpoint Assessment Software market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the AI Clinical Endpoint Assessment Software market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the AI Clinical Endpoint Assessment Software market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of AI Clinical Endpoint Assessment Software include IQVIA, ICON, Perceptive, Clinical Ink, Koneksa, AiCure, Medable, PathAI and Proscia, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

Read the full market overview

This report quantifies the global AI Clinical Endpoint Assessment Software market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.

It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to AI Clinical Endpoint Assessment Software.

Key Companies & Market Share Insights

This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

AI Clinical Endpoint Assessment Software Market by Company

IQVIA

ICON

Perceptive

Clinical Ink

Koneksa

AiCure

Medable

PathAI

Proscia

Paige

IXICO

Median Technologies

VIDA Diagnostics

Image Analysis Group

QMENTA

Cambridge Cognition

Cogstate

Empatica

Cumulus Neuroscience

Rune Labs

VivoSense

NeuraLight

Aural Analytics

Linus Health

Quibim

Perspectum

Brainomix

Taimei Technology

UnionClin

XincereMed

Clario

Medidata

Signant Health

AI Clinical Endpoint Assessment Software Segment by Type

Medical Imaging Endpoints

Digital Pathology Endpoints

Electronic Clinical Outcome Assessment

Wearable and Physiological Endpoints

Voice, Video and Cognitive Endpoints

Multimodal Endpoints

AI Clinical Endpoint Assessment Software Segment by Application

Oncology

Neurology and Psychiatry

Cardiovascular and Metabolic Diseases

Respiratory Diseases

Musculoskeletal and Immunology

Other Therapeutic Areas

AI Clinical Endpoint Assessment Software Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Spain

Russia

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Saudi Arabia

Israel

United Arab Emirates

Turkey

Iran

Egypt

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global AI Clinical Endpoint Assessment Software market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of AI Clinical Endpoint Assessment Software and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of AI Clinical Endpoint Assessment Software.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.

Chapter 6: Detailed analysis of AI Clinical Endpoint Assessment Software companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 13: The main points and conclusions of the report.

More report detail

Tables and figures
List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global AI Clinical Endpoint Assessment Software Market Size by Type (2021-2026) & (US$ Million) Table 6. Global AI Clinical Endpoint Assessment Software Revenue Market Share by Type (2021-2026) Table 7. Global AI Clinical Endpoint Assessment Software Forecasted Market Size by Type (2027-2032) & (US$ Million) Table 8. Global AI Clinical Endpoint Assessment Software Revenue Market Share by Type (2027-2032) Table 9. Global AI Clinical Endpoint Assessment Software Market Size by Application (2021-2026) & (US$ Million) Table 10. Global AI Clinical Endpoint Assessment Software Revenue Market Share by Application (2021-2026) Table 11. Global AI Clinical Endpoint Assessment Software Forecasted Market Size by Application (2027-2032) & (US$ Million) Table 12. Global AI Clinical Endpoint Assessment Software Revenue Market Share by Application (2027-2032) Table 13. Global AI Clinical Endpoint Assessment Software Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Table 14. Global AI Clinical Endpoint Assessment Software Market Size by Region (2021-2026) & (US$ Million) Table 15. Global AI Clinical Endpoint Assessment Software Market Share by Region (2021-2026) Table 16. Global AI Clinical Endpoint Assessment Software Forecasted Market Size by Region (2027-2032) & (US$ Million) Table 17. Global AI Clinical Endpoint Assessment Software Market Share by Region (2027-2032) Table 18. AI Clinical Endpoint Assessment Software Industry Trends Table 19. AI Clinical Endpoint Assessment Software Industry Drivers Table 20. AI Clinical Endpoint Assessment Software Industry Opportunities and Challenges Table 21. AI Clinical Endpoint Assessment Software Market Restraints Table 22. Global Top AI Clinical Endpoint Assessment Software Players by Revenue (US$ Million) & (2021-2026) Table 23. Global AI Clinical Endpoint Assessment Software Revenue Market Share by Players (2021-2026) Table 24. Global AI Clinical Endpoint Assessment Software Industry Players Ranking, 2024 VS 2025 VS 2026 Table 25. Global Key Players of AI Clinical Endpoint Assessment Software, Headquarters and Area Served Table 26. Global AI Clinical Endpoint Assessment Software Players, Product Type & Application Table 27. Global Players Market Concentration Ratio (CR5 and HHI) Table 28. Global AI Clinical Endpoint Assessment Software by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 29. Players Mergers & Acquisitions, Expansion Plans Table 30. North America AI Clinical Endpoint Assessment Software Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 31. North America AI Clinical Endpoint Assessment Software Market Size by Country (2021-2026) & (US$ Million) Table 32. North America AI Clinical Endpoint Assessment Software Market Size by Country (2027-2032) & (US$ Million) Table 33. Europe AI Clinical Endpoint Assessment Software Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 34. Europe AI Clinical Endpoint Assessment Software Market Size by Country (2021-2026) & (US$ Million) Table 35. Europe AI Clinical Endpoint Assessment Software Market Size by Country (2027-2032) & (US$ Million) Table 36. Asia Pacific AI Clinical Endpoint Assessment Software Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 37. Asia Pacific AI Clinical Endpoint Assessment Software Market Size by Region (2021-2026) & (US$ Million) Table 38. Asia Pacific AI Clinical Endpoint Assessment Software Market Size by Country (2027-2032) & (US$ Million) Table 39. South America AI Clinical Endpoint Assessment Software Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 40. South America AI Clinical Endpoint Assessment Software Market Size by Country (2021-2026) & (US$ Million) Table 41. South America AI Clinical Endpoint Assessment Software Market Size by Country (2027-2032) & (US$ Million) Table 42. Middle East & Africa AI Clinical Endpoint Assessment Software Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 43. Middle East & Africa AI Clinical Endpoint Assessment Software Market Size by Country (2021-2026) & (US$ Million) Table 44. Middle East & Africa AI Clinical Endpoint Assessment Software Market Size by Country (2027-2032) & (US$ Million) Table 45. IQVIA Company Information Table 46. IQVIA Business Overview Table 47. IQVIA Revenue in AI Clinical Endpoint Assessment Software Business (2021-2026) & (US$ Million) Table 48. IQVIA AI Clinical Endpoint Assessment Software Product Portfolio Table 49. IQVIA Recent Developments Table 50. ICON Company Information Table 51. ICON Business Overview Table 52. ICON Revenue in AI Clinical Endpoint Assessment Software Business (2021-2026) & (US$ Million) Table 53. ICON AI Clinical Endpoint Assessment Software Product Portfolio Table 54. ICON Recent Developments Table 55. Perceptive Company Information Table 56. Perceptive Business Overview Table 57. Perceptive Revenue in AI Clinical Endpoint Assessment Software Business (2021-2026) & (US$ Million) Table 58. Perceptive AI Clinical Endpoint Assessment Software Product Portfolio Table 59. Perceptive Recent Developments Table 60. Clinical Ink Company Information Table 61. Clinical Ink Business Overview Table 62. Clinical Ink Revenue in AI Clinical Endpoint Assessment Software Business (2021-2026) & (US$ Million) Table 63. Clinical Ink AI Clinical Endpoint Assessment Software Product Portfolio Table 64. Clinical Ink Recent Developments Table 65. Koneksa Company Information Table 66. Koneksa Business Overview Table 67. Koneksa Revenue in AI Clinical Endpoint Assessment Software Business (2021-2026) & (US$ Million) Table 68. Koneksa AI Clinical Endpoint Assessment Software Product Portfolio Table 69. Koneksa Recent Developments Table 70. AiCure Company Information Table 71. AiCure Business Overview Table 72. AiCure Revenue in AI Clinical Endpoint Assessment Software Business (2021-2026) & (US$ Million) Table 73. AiCure AI Clinical Endpoint Assessment Software Product Portfolio Table 74. AiCure Recent Developments Table 75. Medable Company Information Table 76. Medable Business Overview Table 77. Medable Revenue in AI Clinical Endpoint Assessment Software Business (2021-2026) & (US$ Million) Table 78. Medable AI Clinical Endpoint Assessment Software Product Portfolio Table 79. Medable Recent Developments Table 80. PathAI Company Information Table 81. PathAI Business Overview Table 82. PathAI Revenue in AI Clinical Endpoint Assessment Software Business (2021-2026) & (US$ Million) Table 83. PathAI AI Clinical Endpoint Assessment Software Product Portfolio Table 84. PathAI Recent Developments Table 85. Proscia Company Information Table 86. Proscia Business Overview Table 87. Proscia Revenue in AI Clinical Endpoint Assessment Software Business (2021-2026) & (US$ Million) Table 88. Proscia AI Clinical Endpoint Assessment Software Product Portfolio Table 89. Proscia Recent Developments Table 90. Paige Company Information Table 91. Paige Business Overview Table 92. Paige Revenue in AI Clinical Endpoint Assessment Software Business (2021-2026) & (US$ Million) Table 93. Paige AI Clinical Endpoint Assessment Software Product Portfolio Table 94. Paige Recent Developments Table 95. IXICO Company Information Table 96. IXICO Business Overview Table 97. IXICO Revenue in AI Clinical Endpoint Assessment Software Business (2021-2026) & (US$ Million) Table 98. IXICO AI Clinical Endpoint Assessment Software Product Portfolio Table 99. IXICO Recent Developments Table 100. Median Technologies Company Information Table 101. Median Technologies Business Overview Table 102. Median Technologies Revenue in AI Clinical Endpoint Assessment Software Business (2021-2026) & (US$ Million) Table 103. Median Technologies AI Clinical Endpoint Assessment Software Product Portfolio Table 104. Median Technologies Recent Developments Table 105. VIDA Diagnostics Company Information Table 106. VIDA Diagnostics Business Overview Table 107. VIDA Diagnostics Revenue in AI Clinical Endpoint Assessment Software Business (2021-2026) & (US$ Million) Table 108. VIDA Diagnostics AI Clinical Endpoint Assessment Software Product Portfolio Table 109. VIDA Diagnostics Recent Developments Table 110. Image Analysis Group Company Information Table 111. Image Analysis Group Business Overview Table 112. Image Analysis Group Revenue in AI Clinical Endpoint Assessment Software Business (2021-2026) & (US$ Million) Table 113. Image Analysis Group AI Clinical Endpoint Assessment Software Product Portfolio Table 114. Image Analysis Group Recent Developments Table 115. QMENTA Company Information Table 116. QMENTA Business Overview Table 117. QMENTA Revenue in AI Clinical Endpoint Assessment Software Business (2021-2026) & (US$ Million) Table 118. QMENTA AI Clinical Endpoint Assessment Software Product Portfolio Table 119. QMENTA Recent Developments Table 120. Cambridge Cognition Company Information Table 121. Cambridge Cognition Business Overview Table 122. Cambridge Cognition Revenue in AI Clinical Endpoint Assessment Software Business (2021-2026) & (US$ Million) Table 123. Cambridge Cognition AI Clinical Endpoint Assessment Software Product Portfolio Table 124. Cambridge Cognition Recent Developments Table 125. Cogstate Company Information Table 126. Cogstate Business Overview Table 127. Cogstate Revenue in AI Clinical Endpoint Assessment Software Business (2021-2026) & (US$ Million) Table 128. Cogstate AI Clinical Endpoint Assessment Software Product Portfolio Table 129. Cogstate Recent Developments Table 130. Empatica Company Information Table 131. Empatica Business Overview Table 132. Empatica Revenue in AI Clinical Endpoint Assessment Software Business (2021-2026) & (US$ Million) Table 133. Empatica AI Clinical Endpoint Assessment Software Product Portfolio Table 134. Empatica Recent Developments Table 135. Cumulus Neuroscience Company Information Table 136. Cumulus Neuroscience Business Overview Table 137. Cumulus Neuroscience Revenue in AI Clinical Endpoint Assessment Software Business (2021-2026) & (US$ Million) Table 138. Cumulus Neuroscience AI Clinical Endpoint Assessment Software Product Portfolio Table 139. Cumulus Neuroscience Recent Developments Table 140. Rune Labs Company Information Table 141. Rune Labs Business Overview Table 142. Rune Labs Revenue in AI Clinical Endpoint Assessment Software Business (2021-2026) & (US$ Million) Table 143. Rune Labs AI Clinical Endpoint Assessment Software Product Portfolio Table 144. Rune Labs Recent Developments Table 145. VivoSense Company Information Table 146. VivoSense Business Overview Table 147. VivoSense Revenue in AI Clinical Endpoint Assessment Software Business (2021-2026) & (US$ Million) Table 148. VivoSense AI Clinical Endpoint Assessment Software Product Portfolio Table 149. VivoSense Recent Developments Table 150. NeuraLight Company Information Table 151. NeuraLight Business Overview Table 152. NeuraLight Revenue in AI Clinical Endpoint Assessment Software Business (2021-2026) & (US$ Million) Table 153. NeuraLight AI Clinical Endpoint Assessment Software Product Portfolio Table 154. NeuraLight Recent Developments Table 155. Aural Analytics Company Information Table 156. Aural Analytics Business Overview Table 157. Aural Analytics Revenue in AI Clinical Endpoint Assessment Software Business (2021-2026) & (US$ Million) Table 158. Aural Analytics AI Clinical Endpoint Assessment Software Product Portfolio Table 159. Aural Analytics Recent Developments Table 160. Linus Health Company Information Table 161. Linus Health Business Overview Table 162. Linus Health Revenue in AI Clinical Endpoint Assessment Software Business (2021-2026) & (US$ Million) Table 163. Linus Health AI Clinical Endpoint Assessment Software Product Portfolio Table 164. Linus Health Recent Developments Table 165. Quibim Company Information Table 166. Quibim Business Overview Table 167. Quibim Revenue in AI Clinical Endpoint Assessment Software Business (2021-2026) & (US$ Million) Table 168. Quibim AI Clinical Endpoint Assessment Software Product Portfolio Table 169. Quibim Recent Developments Table 170. Perspectum Company Information Table 171. Perspectum Business Overview Table 172. Perspectum Revenue in AI Clinical Endpoint Assessment Software Business (2021-2026) & (US$ Million) Table 173. Perspectum AI Clinical Endpoint Assessment Software Product Portfolio Table 174. Perspectum Recent Developments Table 175. Brainomix Company Information Table 176. Brainomix Business Overview Table 177. Brainomix Revenue in AI Clinical Endpoint Assessment Software Business (2021-2026) & (US$ Million) Table 178. Brainomix AI Clinical Endpoint Assessment Software Product Portfolio Table 179. Brainomix Recent Developments Table 180. Taimei Technology Company Information Table 181. Taimei Technology Business Overview Table 182. Taimei Technology Revenue in AI Clinical Endpoint Assessment Software Business (2021-2026) & (US$ Million) Table 183. Taimei Technology AI Clinical Endpoint Assessment Software Product Portfolio Table 184. Taimei Technology Recent Developments Table 185. UnionClin Company Information Table 186. UnionClin Business Overview Table 187. UnionClin Revenue in AI Clinical Endpoint Assessment Software Business (2021-2026) & (US$ Million) Table 188. UnionClin AI Clinical Endpoint Assessment Software Product Portfolio Table 189. UnionClin Recent Developments Table 190. XincereMed Company Information Table 191. XincereMed Business Overview Table 192. XincereMed Revenue in AI Clinical Endpoint Assessment Software Business (2021-2026) & (US$ Million) Table 193. XincereMed AI Clinical Endpoint Assessment Software Product Portfolio Table 194. XincereMed Recent Developments Table 195. Clario Company Information Table 196. Clario Business Overview Table 197. Clario Revenue in AI Clinical Endpoint Assessment Software Business (2021-2026) & (US$ Million) Table 198. Clario AI Clinical Endpoint Assessment Software Product Portfolio Table 199. Clario Recent Developments Table 200. Medidata Company Information Table 201. Medidata Business Overview Table 202. Medidata Revenue in AI Clinical Endpoint Assessment Software Business (2021-2026) & (US$ Million) Table 203. Medidata AI Clinical Endpoint Assessment Software Product Portfolio Table 204. Medidata Recent Developments Table 205. Signant Health Company Information Table 206. Signant Health Business Overview Table 207. Signant Health Revenue in AI Clinical Endpoint Assessment Software Business (2021-2026) & (US$ Million) Table 208. Signant Health AI Clinical Endpoint Assessment Software Product Portfolio Table 209. Signant Health Recent Developments Table 210. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. AI Clinical Endpoint Assessment Software Product Image Figure 5. Global AI Clinical Endpoint Assessment Software Market Size Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 6. Global AI Clinical Endpoint Assessment Software Market Share by Type: 2025 VS 2032 Figure 7. Medical Imaging Endpoints Product Figure 8. Digital Pathology Endpoints Product Figure 9. Electronic Clinical Outcome Assessment Product Figure 10. Wearable and Physiological Endpoints Product Figure 11. Voice, Video and Cognitive Endpoints Product Figure 12. Multimodal Endpoints Product Figure 13. Global AI Clinical Endpoint Assessment Software Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 14. Global AI Clinical Endpoint Assessment Software Market Share by Application: 2025 VS 2032 Figure 15. Oncology Product Figure 16. Neurology and Psychiatry Product Figure 17. Cardiovascular and Metabolic Diseases Product Figure 18. Respiratory Diseases Product Figure 19. Musculoskeletal and Immunology Product Figure 20. Other Therapeutic Areas Product Figure 21. Global AI Clinical Endpoint Assessment Software Market Size (US$ Million), Year-over-Year: 2021-2032 Figure 22. Global AI Clinical Endpoint Assessment Software Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 23. Global AI Clinical Endpoint Assessment Software Market Share by Region: 2025 VS 2032 Figure 24. Global AI Clinical Endpoint Assessment Software Market Share by Players in 2025 Figure 25. Global AI Clinical Endpoint Assessment Software Manufacturers Established Date Figure 26. Global Top 5 and 10 AI Clinical Endpoint Assessment Software Players Market Share by Revenue in 2025 Figure 27. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 28. North America AI Clinical Endpoint Assessment Software Market Size YoY Growth (2021-2032) & (US$ Million) Figure 29. North America AI Clinical Endpoint Assessment Software Market Share by Country (2021-2032) Figure 30. United States AI Clinical Endpoint Assessment Software Market Size YoY Growth (2021-2032) & (US$ Million) Figure 31. Canada AI Clinical Endpoint Assessment Software Market Size YoY Growth (2021-2032) & (US$ Million) Figure 32. Mexico AI Clinical Endpoint Assessment Software Market Share by Country (2021-2032) Figure 33. Europe AI Clinical Endpoint Assessment Software Market Size YoY Growth (2021-2032) & (US$ Million) Figure 34. Europe AI Clinical Endpoint Assessment Software Market Share by Country (2021-2032) Figure 35. Germany AI Clinical Endpoint Assessment Software Market Size YoY Growth (2021-2032) & (US$ Million) Figure 36. France AI Clinical Endpoint Assessment Software Market Size YoY Growth (2021-2032) & (US$ Million) Figure 37. U.K. AI Clinical Endpoint Assessment Software Market Size YoY Growth (2021-2032) & (US$ Million) Figure 38. Italy AI Clinical Endpoint Assessment Software Market Size YoY Growth (2021-2032) & (US$ Million) Figure 39. Spain AI Clinical Endpoint Assessment Software Market Size YoY Growth (2021-2032) & (US$ Million) Figure 40. Russia AI Clinical Endpoint Assessment Software Market Size YoY Growth (2021-2032) & (US$ Million) Figure 41. Netherlands AI Clinical Endpoint Assessment Software Market Size YoY Growth (2021-2032) & (US$ Million) Figure 42. Nordic Countries AI Clinical Endpoint Assessment Software Market Size YoY Growth (2021-2032) & (US$ Million) Figure 43. Asia-Pacific AI Clinical Endpoint Assessment Software Market Size YoY Growth (2021-2032) & (US$ Million) Figure 44. Asia-Pacific AI Clinical Endpoint Assessment Software Market Share by Country (2021-2032) Figure 45. China AI Clinical Endpoint Assessment Software Market Size YoY Growth (2021-2032) & (US$ Million) Figure 46. Japan AI Clinical Endpoint Assessment Software Market Size YoY Growth (2021-2032) & (US$ Million) Figure 47. South Korea AI Clinical Endpoint Assessment Software Market Size YoY Growth (2021-2032) & (US$ Million) Figure 48. India AI Clinical Endpoint Assessment Software Market Size YoY Growth (2021-2032) & (US$ Million) Figure 49. India AI Clinical Endpoint Assessment Software Market Share by Country (2021-2032) Figure 50. Australia AI Clinical Endpoint Assessment Software Market Size YoY Growth (2021-2032) & (US$ Million) Figure 51. China Taiwan AI Clinical Endpoint Assessment Software Market Size YoY Growth (2021-2032) & (US$ Million) Figure 52. Southeast Asia AI Clinical Endpoint Assessment Software Market Size YoY Growth (2021-2032) & (US$ Million) Figure 53. South America AI Clinical Endpoint Assessment Software Market Size YoY Growth (2021-2032) & (US$ Million) Figure 54. South America AI Clinical Endpoint Assessment Software Market Share by Country (2021-2032) Figure 55. Brazil AI Clinical Endpoint Assessment Software Market Size YoY Growth (2021-2032) & (US$ Million) Figure 56. Argentina AI Clinical Endpoint Assessment Software Market Size YoY Growth (2021-2032) & (US$ Million) Figure 57. Chile AI Clinical Endpoint Assessment Software Market Size YoY Growth (2021-2032) & (US$ Million) Figure 58. Colombia AI Clinical Endpoint Assessment Software Market Size YoY Growth (2021-2032) & (US$ Million) Figure 59. Peru AI Clinical Endpoint Assessment Software Market Size YoY Growth (2021-2032) & (US$ Million) Figure 60. IQVIA Revenue Growth Rate in AI Clinical Endpoint Assessment Software Business (2021-2026) Figure 61. ICON Revenue Growth Rate in AI Clinical Endpoint Assessment Software Business (2021-2026) Figure 62. Perceptive Revenue Growth Rate in AI Clinical Endpoint Assessment Software Business (2021-2026) Figure 63. Clinical Ink Revenue Growth Rate in AI Clinical Endpoint Assessment Software Business (2021-2026) Figure 64. Koneksa Revenue Growth Rate in AI Clinical Endpoint Assessment Software Business (2021-2026) Figure 65. AiCure Revenue Growth Rate in AI Clinical Endpoint Assessment Software Business (2021-2026) Figure 66. Medable Revenue Growth Rate in AI Clinical Endpoint Assessment Software Business (2021-2026) Figure 67. PathAI Revenue Growth Rate in AI Clinical Endpoint Assessment Software Business (2021-2026) Figure 68. Proscia Revenue Growth Rate in AI Clinical Endpoint Assessment Software Business (2021-2026) Figure 69. Paige Revenue Growth Rate in AI Clinical Endpoint Assessment Software Business (2021-2026) Figure 70. IXICO Revenue Growth Rate in AI Clinical Endpoint Assessment Software Business (2021-2026) Figure 71. Median Technologies Revenue Growth Rate in AI Clinical Endpoint Assessment Software Business (2021-2026) Figure 72. VIDA Diagnostics Revenue Growth Rate in AI Clinical Endpoint Assessment Software Business (2021-2026) Figure 73. Image Analysis Group Revenue Growth Rate in AI Clinical Endpoint Assessment Software Business (2021-2026) Figure 74. QMENTA Revenue Growth Rate in AI Clinical Endpoint Assessment Software Business (2021-2026) Figure 75. Cambridge Cognition Revenue Growth Rate in AI Clinical Endpoint Assessment Software Business (2021-2026) Figure 76. Cogstate Revenue Growth Rate in AI Clinical Endpoint Assessment Software Business (2021-2026) Figure 77. Empatica Revenue Growth Rate in AI Clinical Endpoint Assessment Software Business (2021-2026) Figure 78. Cumulus Neuroscience Revenue Growth Rate in AI Clinical Endpoint Assessment Software Business (2021-2026) Figure 79. Rune Labs Revenue Growth Rate in AI Clinical Endpoint Assessment Software Business (2021-2026) Figure 80. VivoSense Revenue Growth Rate in AI Clinical Endpoint Assessment Software Business (2021-2026) Figure 81. NeuraLight Revenue Growth Rate in AI Clinical Endpoint Assessment Software Business (2021-2026) Figure 82. Aural Analytics Revenue Growth Rate in AI Clinical Endpoint Assessment Software Business (2021-2026) Figure 83. Linus Health Revenue Growth Rate in AI Clinical Endpoint Assessment Software Business (2021-2026) Figure 84. Quibim Revenue Growth Rate in AI Clinical Endpoint Assessment Software Business (2021-2026) Figure 85. Perspectum Revenue Growth Rate in AI Clinical Endpoint Assessment Software Business (2021-2026) Figure 86. Brainomix Revenue Growth Rate in AI Clinical Endpoint Assessment Software Business (2021-2026) Figure 87. Taimei Technology Revenue Growth Rate in AI Clinical Endpoint Assessment Software Business (2021-2026) Figure 88. UnionClin Revenue Growth Rate in AI Clinical Endpoint Assessment Software Business (2021-2026) Figure 89. XincereMed Revenue Growth Rate in AI Clinical Endpoint Assessment Software Business (2021-2026) Figure 90. Clario Revenue Growth Rate in AI Clinical Endpoint Assessment Software Business (2021-2026) Figure 91. Medidata Revenue Growth Rate in AI Clinical Endpoint Assessment Software Business (2021-2026) Figure 92. Signant Health Revenue Growth Rate in AI Clinical Endpoint Assessment Software Business (2021-2026)

Scope & coverage.

Types
  • Medical Imaging Endpoints
  • Digital Pathology Endpoints
  • Electronic Clinical Outcome Assessment
  • Wearable and Physiological Endpoints
  • Voice, Video and Cognitive Endpoints
  • Multimodal Endpoints
Applications
  • Oncology
  • Neurology and Psychiatry
  • Cardiovascular and Metabolic Diseases
  • Respiratory Diseases
  • Musculoskeletal and Immunology
  • Other Therapeutic Areas
Companies covered
  • IQVIA
  • ICON
  • Perceptive
  • Clinical Ink
  • Koneksa
  • AiCure
  • Medable
  • PathAI
  • Proscia
  • Paige
  • IXICO
  • Median Technologies
  • VIDA Diagnostics
  • Image Analysis Group
  • QMENTA
  • Cambridge Cognition
  • Cogstate
  • Empatica
  • Cumulus Neuroscience
  • Rune Labs
  • VivoSense
  • NeuraLight
  • Aural Analytics
  • Linus Health
  • Quibim
  • Perspectum
  • Brainomix
  • Taimei Technology
  • UnionClin
  • XincereMed
  • Clario
  • Medidata
  • Signant Health

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 AI Clinical Endpoint Assessment Software by Type
  3. 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
  4. 2.2.2 Medical Imaging Endpoints
  5. 2.2.3 Digital Pathology Endpoints
  6. 2.2.4 Electronic Clinical Outcome Assessment
  7. 2.2.5 Wearable and Physiological Endpoints
  8. 2.2.6 Voice, Video and Cognitive Endpoints
  9. 2.2.7 Multimodal Endpoints
  10. 2.3 AI Clinical Endpoint Assessment Software by Application
  11. 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
  12. 2.3.2 Oncology
  13. 2.3.3 Neurology and Psychiatry
  14. 2.3.4 Cardiovascular and Metabolic Diseases
  15. 2.3.5 Respiratory Diseases
  16. 2.3.6 Musculoskeletal and Immunology
  17. 2.3.7 Other Therapeutic Areas
  18. 2.4 Assumptions and Limitations
3 AI Clinical Endpoint Assessment Software Breakdown Data by Type
  1. 3.1 Global AI Clinical Endpoint Assessment Software Historic Market Size by Type (2021-2026)
  2. 3.2 Global AI Clinical Endpoint Assessment Software Forecasted Market Size by Type (2027-2032)
4 AI Clinical Endpoint Assessment Software Breakdown Data by Application
  1. 4.1 Global AI Clinical Endpoint Assessment Software Historic Market Size by Application (2021-2026)
  2. 4.2 Global AI Clinical Endpoint Assessment Software Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
  1. 5.1 Global AI Clinical Endpoint Assessment Software Market Perspective (2021-2032)
  2. 5.2 Global AI Clinical Endpoint Assessment Software Growth Trends by Region
  3. 5.2.1 Global AI Clinical Endpoint Assessment Software Market Size by Region: 2021 VS 2025 VS 2032
  4. 5.2.2 AI Clinical Endpoint Assessment Software Historic Market Size by Region (2021-2026)
  5. 5.2.3 AI Clinical Endpoint Assessment Software Forecasted Market Size by Region (2027-2032)
  6. 5.3 AI Clinical Endpoint Assessment Software Market Dynamics
  7. 5.3.1 AI Clinical Endpoint Assessment Software Industry Trends
  8. 5.3.2 AI Clinical Endpoint Assessment Software Market Drivers
  9. 5.3.3 AI Clinical Endpoint Assessment Software Market Challenges
  10. 5.3.4 AI Clinical Endpoint Assessment Software Market Restraints
6 Market Competitive Landscape by Players
  1. 6.1 Global Top AI Clinical Endpoint Assessment Software Players by Revenue
  2. 6.1.1 Global Top AI Clinical Endpoint Assessment Software Players by Revenue (2021-2026)
  3. 6.1.2 Global AI Clinical Endpoint Assessment Software Revenue Market Share by Players (2021-2026)
  4. 6.2 Global AI Clinical Endpoint Assessment Software Industry Players Ranking, 2023 VS 2024 VS 2025
  5. 6.3 Global Key Players of AI Clinical Endpoint Assessment Software Head Office and Area Served
  6. 6.4 Global AI Clinical Endpoint Assessment Software Players, Product Type & Application
  7. 6.5 Global AI Clinical Endpoint Assessment Software Manufacturers Established Date
  8. 6.6 Global AI Clinical Endpoint Assessment Software Market CR5 and HHI
  9. 6.7 Global Players Mergers & Acquisition
7 North America
  1. 7.1 North America AI Clinical Endpoint Assessment Software Market Size (2021-2032)
  2. 7.2 North America AI Clinical Endpoint Assessment Software Market Growth Rate by Country: 2021 VS 2025 VS 2032
  3. 7.3 North America AI Clinical Endpoint Assessment Software Market Size by Country (2021-2026)
  4. 7.4 North America AI Clinical Endpoint Assessment Software Market Size by Country (2027-2032)
  5. 7.5 United States
  6. 7.5 United States
  7. 7.6 Canada
  8. 7.7 Mexico
8 Europe
  1. 8.1 Europe AI Clinical Endpoint Assessment Software Market Size (2021-2032)
  2. 8.2 Europe AI Clinical Endpoint Assessment Software Market Growth Rate by Country: 2021 VS 2025 VS 2032
  3. 8.3 Europe AI Clinical Endpoint Assessment Software Market Size by Country (2021-2026)
  4. 8.4 Europe AI Clinical Endpoint Assessment Software Market Size by Country (2027-2032)
  5. 8.5 Germany
  6. 8.6 France
  7. 8.7 U.K.
  8. 8.8 Italy
  9. 8.9 Spain
  10. 8.10 Russia
  11. 8.11 Netherlands
  12. 8.12 Nordic Countries
9 Asia-Pacific
  1. 9.1 Asia-Pacific AI Clinical Endpoint Assessment Software Market Size (2021-2032)
  2. 9.2 Asia-Pacific AI Clinical Endpoint Assessment Software Market Growth Rate by Country: 2021 VS 2025 VS 2032
  3. 9.3 Asia-Pacific AI Clinical Endpoint Assessment Software Market Size by Country (2021-2026)
  4. 9.4 Asia-Pacific AI Clinical Endpoint Assessment Software Market Size by Country (2027-2032)
  5. 9.5 China
  6. 9.6 Japan
  7. 9.7 South Korea
  8. 9.8 India
  9. 9.9 Australia
  10. 9.10 China Taiwan
  11. 9.11 Southeast Asia
10 South America
  1. 10.1 South America AI Clinical Endpoint Assessment Software Market Size (2021-2032)
  2. 10.2 South America AI Clinical Endpoint Assessment Software Market Growth Rate by Country: 2021 VS 2025 VS 2032
  3. 10.3 South America AI Clinical Endpoint Assessment Software Market Size by Country (2021-2026)
  4. 10.4 South America AI Clinical Endpoint Assessment Software Market Size by Country (2027-2032)
  5. 10.5 Brazil
  6. 10.6 Argentina
  7. 10.7 Chile
  8. 10.8 Colombia
  9. 10.9 Peru
11 Middle East & Africa
  1. 11.1 Middle East & Africa AI Clinical Endpoint Assessment Software Market Size (2021-2032)
  2. 11.2 Middle East & Africa AI Clinical Endpoint Assessment Software Market Growth Rate by Country: 2021 VS 2025 VS 2032
  3. 11.3 Middle East & Africa AI Clinical Endpoint Assessment Software Market Size by Country (2021-2026)
  4. 11.4 Middle East & Africa AI Clinical Endpoint Assessment Software Market Size by Country (2027-2032)
  5. 11.5 Saudi Arabia
  6. 11.6 Israel
  7. 11.7 United Arab Emirates
  8. 11.8 Turkey
  9. 11.9 Iran
  10. 11.10 Egypt
12 Players Profiled
  1. 12.1 IQVIA
  2. 12.1.1 IQVIA Company Information
  3. 12.1.2 IQVIA Business Overview
  4. 12.1.3 IQVIA Revenue in AI Clinical Endpoint Assessment Software Business (2021-2026)
  5. 12.1.4 IQVIA AI Clinical Endpoint Assessment Software Product Portfolio
  6. 12.1.5 IQVIA Recent Developments
  7. 12.2 ICON
  8. 12.2.1 ICON Company Information
  9. 12.2.2 ICON Business Overview
  10. 12.2.3 ICON Revenue in AI Clinical Endpoint Assessment Software Business (2021-2026)
  11. 12.2.4 ICON AI Clinical Endpoint Assessment Software Product Portfolio
  12. 12.2.5 ICON Recent Developments
  13. 12.3 Perceptive
  14. 12.3.1 Perceptive Company Information
  15. 12.3.2 Perceptive Business Overview
  16. 12.3.3 Perceptive Revenue in AI Clinical Endpoint Assessment Software Business (2021-2026)
  17. 12.3.4 Perceptive AI Clinical Endpoint Assessment Software Product Portfolio
  18. 12.3.5 Perceptive Recent Developments
  19. 12.4 Clinical Ink
  20. 12.4.1 Clinical Ink Company Information
  21. 12.4.2 Clinical Ink Business Overview
  22. 12.4.3 Clinical Ink Revenue in AI Clinical Endpoint Assessment Software Business (2021-2026)
  23. 12.4.4 Clinical Ink AI Clinical Endpoint Assessment Software Product Portfolio
  24. 12.4.5 Clinical Ink Recent Developments
  25. 12.5 Koneksa
  26. 12.5.1 Koneksa Company Information
  27. 12.5.2 Koneksa Business Overview
  28. 12.5.3 Koneksa Revenue in AI Clinical Endpoint Assessment Software Business (2021-2026)
  29. 12.5.4 Koneksa AI Clinical Endpoint Assessment Software Product Portfolio
  30. 12.5.5 Koneksa Recent Developments
  31. 12.6 AiCure
  32. 12.6.1 AiCure Company Information
  33. 12.6.2 AiCure Business Overview
  34. 12.6.3 AiCure Revenue in AI Clinical Endpoint Assessment Software Business (2021-2026)
  35. 12.6.4 AiCure AI Clinical Endpoint Assessment Software Product Portfolio
  36. 12.6.5 AiCure Recent Developments
  37. 12.7 Medable
  38. 12.7.1 Medable Company Information
  39. 12.7.2 Medable Business Overview
  40. 12.7.3 Medable Revenue in AI Clinical Endpoint Assessment Software Business (2021-2026)
  41. 12.7.4 Medable AI Clinical Endpoint Assessment Software Product Portfolio
  42. 12.7.5 Medable Recent Developments
  43. 12.8 PathAI
  44. 12.8.1 PathAI Company Information
  45. 12.8.2 PathAI Business Overview
  46. 12.8.3 PathAI Revenue in AI Clinical Endpoint Assessment Software Business (2021-2026)
  47. 12.8.4 PathAI AI Clinical Endpoint Assessment Software Product Portfolio
  48. 12.8.5 PathAI Recent Developments
  49. 12.9 Proscia
  50. 12.9.1 Proscia Company Information
  51. 12.9.2 Proscia Business Overview
  52. 12.9.3 Proscia Revenue in AI Clinical Endpoint Assessment Software Business (2021-2026)
  53. 12.9.4 Proscia AI Clinical Endpoint Assessment Software Product Portfolio
  54. 12.9.5 Proscia Recent Developments
  55. 12.10 Paige
  56. 12.10.1 Paige Company Information
  57. 12.10.2 Paige Business Overview
  58. 12.10.3 Paige Revenue in AI Clinical Endpoint Assessment Software Business (2021-2026)
  59. 12.10.4 Paige AI Clinical Endpoint Assessment Software Product Portfolio
  60. 12.10.5 Paige Recent Developments
  61. 12.11 IXICO
  62. 12.11.1 IXICO Company Information
  63. 12.11.2 IXICO Business Overview
  64. 12.11.3 IXICO Revenue in AI Clinical Endpoint Assessment Software Business (2021-2026)
  65. 12.11.4 IXICO AI Clinical Endpoint Assessment Software Product Portfolio
  66. 12.11.5 IXICO Recent Developments
  67. 12.12 Median Technologies
  68. 12.12.1 Median Technologies Company Information
  69. 12.12.2 Median Technologies Business Overview
  70. 12.12.3 Median Technologies Revenue in AI Clinical Endpoint Assessment Software Business (2021-2026)
  71. 12.12.4 Median Technologies AI Clinical Endpoint Assessment Software Product Portfolio
  72. 12.12.5 Median Technologies Recent Developments
  73. 12.13 VIDA Diagnostics
  74. 12.13.1 VIDA Diagnostics Company Information
  75. 12.13.2 VIDA Diagnostics Business Overview
  76. 12.13.3 VIDA Diagnostics Revenue in AI Clinical Endpoint Assessment Software Business (2021-2026)
  77. 12.13.4 VIDA Diagnostics AI Clinical Endpoint Assessment Software Product Portfolio
  78. 12.13.5 VIDA Diagnostics Recent Developments
  79. 12.14 Image Analysis Group
  80. 12.14.1 Image Analysis Group Company Information
  81. 12.14.2 Image Analysis Group Business Overview
  82. 12.14.3 Image Analysis Group Revenue in AI Clinical Endpoint Assessment Software Business (2021-2026)
  83. 12.14.4 Image Analysis Group AI Clinical Endpoint Assessment Software Product Portfolio
  84. 12.14.5 Image Analysis Group Recent Developments
  85. 12.15 QMENTA
  86. 12.15.1 QMENTA Company Information
  87. 12.15.2 QMENTA Business Overview
  88. 12.15.3 QMENTA Revenue in AI Clinical Endpoint Assessment Software Business (2021-2026)
  89. 12.15.4 QMENTA AI Clinical Endpoint Assessment Software Product Portfolio
  90. 12.15.5 QMENTA Recent Developments
  91. 12.16 Cambridge Cognition
  92. 12.16.1 Cambridge Cognition Company Information
  93. 12.16.2 Cambridge Cognition Business Overview
  94. 12.16.3 Cambridge Cognition Revenue in AI Clinical Endpoint Assessment Software Business (2021-2026)
  95. 12.16.4 Cambridge Cognition AI Clinical Endpoint Assessment Software Product Portfolio
  96. 12.16.5 Cambridge Cognition Recent Developments
  97. 12.17 Cogstate
  98. 12.17.1 Cogstate Company Information
  99. 12.17.2 Cogstate Business Overview
  100. 12.17.3 Cogstate Revenue in AI Clinical Endpoint Assessment Software Business (2021-2026)
  101. 12.17.4 Cogstate AI Clinical Endpoint Assessment Software Product Portfolio
  102. 12.17.5 Cogstate Recent Developments
  103. 12.18 Empatica
  104. 12.18.1 Empatica Company Information
  105. 12.18.2 Empatica Business Overview
  106. 12.18.3 Empatica Revenue in AI Clinical Endpoint Assessment Software Business (2021-2026)
  107. 12.18.4 Empatica AI Clinical Endpoint Assessment Software Product Portfolio
  108. 12.18.5 Empatica Recent Developments
  109. 12.19 Cumulus Neuroscience
  110. 12.19.1 Cumulus Neuroscience Company Information
  111. 12.19.2 Cumulus Neuroscience Business Overview
  112. 12.19.3 Cumulus Neuroscience Revenue in AI Clinical Endpoint Assessment Software Business (2021-2026)
  113. 12.19.4 Cumulus Neuroscience AI Clinical Endpoint Assessment Software Product Portfolio
  114. 12.19.5 Cumulus Neuroscience Recent Developments
  115. 12.20 Rune Labs
  116. 12.20.1 Rune Labs Company Information
  117. 12.20.2 Rune Labs Business Overview
  118. 12.20.3 Rune Labs Revenue in AI Clinical Endpoint Assessment Software Business (2021-2026)
  119. 12.20.4 Rune Labs AI Clinical Endpoint Assessment Software Product Portfolio
  120. 12.20.5 Rune Labs Recent Developments
  121. 12.21 VivoSense
  122. 12.21.1 VivoSense Company Information
  123. 12.21.2 VivoSense Business Overview
  124. 12.21.3 VivoSense Revenue in AI Clinical Endpoint Assessment Software Business (2021-2026)
  125. 12.21.4 VivoSense AI Clinical Endpoint Assessment Software Product Portfolio
  126. 12.21.5 VivoSense Recent Developments
  127. 12.22 NeuraLight
  128. 12.22.1 NeuraLight Company Information
  129. 12.22.2 NeuraLight Business Overview
  130. 12.22.3 NeuraLight Revenue in AI Clinical Endpoint Assessment Software Business (2021-2026)
  131. 12.22.4 NeuraLight AI Clinical Endpoint Assessment Software Product Portfolio
  132. 12.22.5 NeuraLight Recent Developments
  133. 12.23 Aural Analytics
  134. 12.23.1 Aural Analytics Company Information
  135. 12.23.2 Aural Analytics Business Overview
  136. 12.23.3 Aural Analytics Revenue in AI Clinical Endpoint Assessment Software Business (2021-2026)
  137. 12.23.4 Aural Analytics AI Clinical Endpoint Assessment Software Product Portfolio
  138. 12.23.5 Aural Analytics Recent Developments
  139. 12.24 Linus Health
  140. 12.24.1 Linus Health Company Information
  141. 12.24.2 Linus Health Business Overview
  142. 12.24.3 Linus Health Revenue in AI Clinical Endpoint Assessment Software Business (2021-2026)
  143. 12.24.4 Linus Health AI Clinical Endpoint Assessment Software Product Portfolio
  144. 12.24.5 Linus Health Recent Developments
  145. 12.25 Quibim
  146. 12.25.1 Quibim Company Information
  147. 12.25.2 Quibim Business Overview
  148. 12.25.3 Quibim Revenue in AI Clinical Endpoint Assessment Software Business (2021-2026)
  149. 12.25.4 Quibim AI Clinical Endpoint Assessment Software Product Portfolio
  150. 12.25.5 Quibim Recent Developments
  151. 12.26 Perspectum
  152. 12.26.1 Perspectum Company Information
  153. 12.26.2 Perspectum Business Overview
  154. 12.26.3 Perspectum Revenue in AI Clinical Endpoint Assessment Software Business (2021-2026)
  155. 12.26.4 Perspectum AI Clinical Endpoint Assessment Software Product Portfolio
  156. 12.26.5 Perspectum Recent Developments
  157. 12.27 Brainomix
  158. 12.27.1 Brainomix Company Information
  159. 12.27.2 Brainomix Business Overview
  160. 12.27.3 Brainomix Revenue in AI Clinical Endpoint Assessment Software Business (2021-2026)
  161. 12.27.4 Brainomix AI Clinical Endpoint Assessment Software Product Portfolio
  162. 12.27.5 Brainomix Recent Developments
  163. 12.28 Taimei Technology
  164. 12.28.1 Taimei Technology Company Information
  165. 12.28.2 Taimei Technology Business Overview
  166. 12.28.3 Taimei Technology Revenue in AI Clinical Endpoint Assessment Software Business (2021-2026)
  167. 12.28.4 Taimei Technology AI Clinical Endpoint Assessment Software Product Portfolio
  168. 12.28.5 Taimei Technology Recent Developments
  169. 12.29 UnionClin
  170. 12.29.1 UnionClin Company Information
  171. 12.29.2 UnionClin Business Overview
  172. 12.29.3 UnionClin Revenue in AI Clinical Endpoint Assessment Software Business (2021-2026)
  173. 12.29.4 UnionClin AI Clinical Endpoint Assessment Software Product Portfolio
  174. 12.29.5 UnionClin Recent Developments
  175. 12.30 XincereMed
  176. 12.30.1 XincereMed Company Information
  177. 12.30.2 XincereMed Business Overview
  178. 12.30.3 XincereMed Revenue in AI Clinical Endpoint Assessment Software Business (2021-2026)
  179. 12.30.4 XincereMed AI Clinical Endpoint Assessment Software Product Portfolio
  180. 12.30.5 XincereMed Recent Developments
  181. 12.31 Clario
  182. 12.31.1 Clario Company Information
  183. 12.31.2 Clario Business Overview
  184. 12.31.3 Clario Revenue in AI Clinical Endpoint Assessment Software Business (2021-2026)
  185. 12.31.4 Clario AI Clinical Endpoint Assessment Software Product Portfolio
  186. 12.31.5 Clario Recent Developments
  187. 12.32 Medidata
  188. 12.32.1 Medidata Company Information
  189. 12.32.2 Medidata Business Overview
  190. 12.32.3 Medidata Revenue in AI Clinical Endpoint Assessment Software Business (2021-2026)
  191. 12.32.4 Medidata AI Clinical Endpoint Assessment Software Product Portfolio
  192. 12.32.5 Medidata Recent Developments
  193. 12.33 Signant Health
  194. 12.33.1 Signant Health Company Information
  195. 12.33.2 Signant Health Business Overview
  196. 12.33.3 Signant Health Revenue in AI Clinical Endpoint Assessment Software Business (2021-2026)
  197. 12.33.4 Signant Health AI Clinical Endpoint Assessment Software Product Portfolio
  198. 12.33.5 Signant Health Recent Developments
13 Report Conclusion
    14 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Choose who needs access.
      All options are for this report and research series.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research
      Talk to an analyst